New book explores the rugged adaptability of Sable Island, N.S.’s wild horses

By Devin Stevens, The Canadian Press

HALIFAX — Damian Lidgard has spent 30 years studying and photographing wildlife on Nova Scotia’s Sable Island, and hopes his forthcoming book will give people an appreciation for the beauty and hardiness of the wild horses that have thrived on the remote and inhospitable spit of land for centuries.

The photographer and zoologist with the Department of Fisheries and Oceans says he made his first trip to the isolated, crescent-shaped sandbar — about 40 kilometres long and one kilometre across at its widest point — while working on his PhD in December 1996. Since then, his research on its roughly 20,000-strong seal population has brought him back several times each year, almost without interruption.

While his work with seals is the main reason for his visits, he’s amassed a collection of photos of the island’s most famous residents he’s sharing in his new book “Sable Untamed: The Wild Beauty of Sable Island’s Horses”, coming from Nimbus Publishing in June.

I also just developed a bit of an awe, like an appreciation of how well these horses have adapted to this island,” Lidgard said in a recent interview. “I just felt like I wanted to also be able to share that with people. It’s really inviting people in to be able to see this animal that has been able to adapt to this really hostile environment.”

Sometimes called the “Graveyard of the Atlantic” due to the more than 350 shipwrecks in its surrounding waters, Sable Island is known for its seals, countless seabirds and the roughly 420 wild horses that have called island 290 kilometres southeast of Halifax home since they were introduced in the 1700s.

Lidgard said he didn’t want his new book — his second about the island — to be just another about Sable. He said he used his background to research all the scientific papers about the horse population and integrated it into the work. He’s also included photos from different times of year.

“So there’s pictures of them during the summer when things are wonderful, and there are foals around, and all the grass is green,” he said. “And then it goes through to the winter when it’s harsh winds, and snow and cold temperatures. And so that’s when really the personality of the horses really kind of comes through.”

Lidgard says the ecology of the island impacts the lives of the horses, with the biggest influence being the presence of water. The west side of the island features natural ponds where horses can obtain drinking water, which tends to mean higher growth rates. There’s fewer ponds to the east, so the horse population tends to be smaller. That’s where the horses use their hoofs to dig holes in the beach to access the water table.

Lidgard says there’s multiple bands of horses on Sable with each composed of a stallion, females and their offspring. Bachelor males tend to roam on their own or in small groups.

Researchers travel the island by ATV, and Lidgard says he always keeps a camera with a long lens handy in case he sees something that grabs him. He says he practises a quiet, contemplative form of photography, observing, taking his time and usually snapping just one photograph when something catches his eye.

He says the horses are generally shy, don’t come close to humans and will spook easily with any kind of movement. The foals can be a bit more curious, but the adults tend to guide them away.

Lidgard says Sable is probably his favourite place to be. He sometimes stays there for six weeks at a time and can feel the layers of stress from the mainland stripping away as he eases into the simple life of research, photography, sand and crashing waves.

Visits to Sable Island are managed by Parks Canada, but as a DFO researcher, Lidgard has a lot of access. He counts himself lucky that he can spend so much time on the island while other photographers might have a just a few hours, or maybe a day.

I always find it surprising that when you’re flying out to the island and you’re flying over water, open ocean, for an hour or something and then this sandbar appears on the horizon, which is in itself a surprising thing you witness,” he said.

“Then, as you’re flying over the island to see there are horses… is even more surprising and just makes you realize how resilient those animals are to be able to survive in such a remote and somewhat hostile environment.”

This report by The Canadian Press was first published May 31, 2026.

Devin Stevens, The Canadian Press



Keep it Factual
Add CityNews Toronto as a trusted source on Google to see more local stories from us.

Top Stories

Weight-loss drugs shaping up to be a boon for grocers' pharmacy units

While discount stores have been a bright spot recently for major grocery chains, other units within their empires have been quietly seeing a sales boom: their pharmacies. And it's largely coming from rising sales of weight-loss drugs. The popularity of Ozempic and other GLP-1 drugs, traditionally used to manage Type 2 diabetes, has exploded in recent years thanks to their weight-loss side effects. And as cheaper, generic versions become more widely available, uptake is only expected to rise further. Semaglutides, or GLP-1s as they're sometimes called, are the active ingredient in drugs like Ozempic. For grocers that have pharmacy units, signs of that growth are already noticeable in their financial reports. Loblaw Cos. Ltd., which owns Shoppers Drug Mart and Pharmaprix, reported a roughly 40 per cent surge in GLP-1 sales in each of its last two quarters. "We are beginning to see the impact of GLP-1 drugs going generic. It's still very early, but the initial indications are encouraging," Per Bank, chief executive of Loblaw, told analysts on an earnings call in July. Loblaw executives are projecting double-digit growth for GLP-1 sales in 2027. Metro Inc.'s outgoing chief executive, Eric La Flèche, struck a similar note during its earnings call last month. Metro owns Jean Coutu pharmacies. "Demand fundamentals remain strong with early evidence of increased patient adoption and higher prescription volumes," he said. Loblaw reported its drug retail same-store sales grew 4.6 per cent in its latest quarter, while Metro's pharmacy same-store sales were up 4.8 per cent. Both outpaced same-store sales metrics for food. The gains were driven by the prescriptions category. Even though generic versions of the drug mean lower prices, the growth in volume is still a net positive. "As generic supply continues to build, we expect ongoing expansion of the GLP-1 category to drive low-teens volume and contribution growth," La Flèche told analysts. That's "indicating that higher volumes should more than offset a meaningful portion of the price pressure from generalization," Veritas analyst Kathleen Wong said in a note about Metro's quarterly results in August. "The resulting price deflation is therefore likely to pressure pharmacy same-store sales measured in dollars, but Metro’s early experience suggests that increased accessibility and prescription volumes can offset part of that pressure at the contribution level." Health Canada has so far approved three generic semaglutide products, and is continuing to review more — making the country the first among G7 nations to do so. These used to be called the drug of the rich, said Amar Singh, senior director and head of Canadian retail insights at Kantar. "This drug was expensive, and now, with the generics coming out, this is increasing penetration as the cost has come down and more people can afford it," he said in an interview. Half of the respondents in a Leger poll from March said insurance coverage or a lower-cost generic would increase their likelihood of using a GLP-1. More than half cited weight loss as their primary reason for taking the drug. At that time, eight per cent — or three million Canadians — were on prescription GLP-1s, the survey suggested. With generics increasingly available in the market, Singh said he expects uptake to rise to about 20 per cent over the next year or two. That surge comes as Loblaw and Metro are expanding their pharmacy networks. Loblaw expects to have opened about 200 stores over the last three years, and roughly half are pharmacies, Wong said. Meanwhile, Empire acquired nine Morelli’s pharmacies in Ontario last month that are already situated within some Longo’s grocery stores. Jo-Ann McArthur, president of Nourish Food Marketing, said the increasing popularity of weight-loss drugs could be an opportunity for grocers to tailor customer experiences, especially as attitudes toward food change among weight-loss drug users. For instance, she said grocers could suggest GLP-1-friendly foods and offer meal planning through their loyalty apps, offer health-care insights for those on and off drugs, streamline store shelf labelling and market items that are weight-loss drug friendly. Late last year, Loblaw launched an online weight-management program for people to connect with health care practitioners and see if they qualify for the drugs. "Where they make more money (is) by providing more services and more advice and just making it easier for the consumer to just stay loyal," she said. And it's not just about keeping GLP-1 users within the same ecosystem. "People who are on these drugs often are controlling the whole family's shopping and meal prep," she said. "If one person in a family is on a diet, the whole family is on a diet." This report by The Canadian Press was first published Sept. 13, 2026.

1h ago

Top Stories

Weight-loss drugs shaping up to be a boon for grocers' pharmacy units

While discount stores have been a bright spot recently for major grocery chains, other units within their empires have been quietly seeing a sales boom: their pharmacies. And it's largely coming from rising sales of weight-loss drugs. The popularity of Ozempic and other GLP-1 drugs, traditionally used to manage Type 2 diabetes, has exploded in recent years thanks to their weight-loss side effects. And as cheaper, generic versions become more widely available, uptake is only expected to rise further. Semaglutides, or GLP-1s as they're sometimes called, are the active ingredient in drugs like Ozempic. For grocers that have pharmacy units, signs of that growth are already noticeable in their financial reports. Loblaw Cos. Ltd., which owns Shoppers Drug Mart and Pharmaprix, reported a roughly 40 per cent surge in GLP-1 sales in each of its last two quarters. "We are beginning to see the impact of GLP-1 drugs going generic. It's still very early, but the initial indications are encouraging," Per Bank, chief executive of Loblaw, told analysts on an earnings call in July. Loblaw executives are projecting double-digit growth for GLP-1 sales in 2027. Metro Inc.'s outgoing chief executive, Eric La Flèche, struck a similar note during its earnings call last month. Metro owns Jean Coutu pharmacies. "Demand fundamentals remain strong with early evidence of increased patient adoption and higher prescription volumes," he said. Loblaw reported its drug retail same-store sales grew 4.6 per cent in its latest quarter, while Metro's pharmacy same-store sales were up 4.8 per cent. Both outpaced same-store sales metrics for food. The gains were driven by the prescriptions category. Even though generic versions of the drug mean lower prices, the growth in volume is still a net positive. "As generic supply continues to build, we expect ongoing expansion of the GLP-1 category to drive low-teens volume and contribution growth," La Flèche told analysts. That's "indicating that higher volumes should more than offset a meaningful portion of the price pressure from generalization," Veritas analyst Kathleen Wong said in a note about Metro's quarterly results in August. "The resulting price deflation is therefore likely to pressure pharmacy same-store sales measured in dollars, but Metro’s early experience suggests that increased accessibility and prescription volumes can offset part of that pressure at the contribution level." Health Canada has so far approved three generic semaglutide products, and is continuing to review more — making the country the first among G7 nations to do so. These used to be called the drug of the rich, said Amar Singh, senior director and head of Canadian retail insights at Kantar. "This drug was expensive, and now, with the generics coming out, this is increasing penetration as the cost has come down and more people can afford it," he said in an interview. Half of the respondents in a Leger poll from March said insurance coverage or a lower-cost generic would increase their likelihood of using a GLP-1. More than half cited weight loss as their primary reason for taking the drug. At that time, eight per cent — or three million Canadians — were on prescription GLP-1s, the survey suggested. With generics increasingly available in the market, Singh said he expects uptake to rise to about 20 per cent over the next year or two. That surge comes as Loblaw and Metro are expanding their pharmacy networks. Loblaw expects to have opened about 200 stores over the last three years, and roughly half are pharmacies, Wong said. Meanwhile, Empire acquired nine Morelli’s pharmacies in Ontario last month that are already situated within some Longo’s grocery stores. Jo-Ann McArthur, president of Nourish Food Marketing, said the increasing popularity of weight-loss drugs could be an opportunity for grocers to tailor customer experiences, especially as attitudes toward food change among weight-loss drug users. For instance, she said grocers could suggest GLP-1-friendly foods and offer meal planning through their loyalty apps, offer health-care insights for those on and off drugs, streamline store shelf labelling and market items that are weight-loss drug friendly. Late last year, Loblaw launched an online weight-management program for people to connect with health care practitioners and see if they qualify for the drugs. "Where they make more money (is) by providing more services and more advice and just making it easier for the consumer to just stay loyal," she said. And it's not just about keeping GLP-1 users within the same ecosystem. "People who are on these drugs often are controlling the whole family's shopping and meal prep," she said. "If one person in a family is on a diet, the whole family is on a diet." This report by The Canadian Press was first published Sept. 13, 2026.

1h ago

Most Watched Today